Portfolio / Bioxell

bioxell.gif


Prior to their acquisition by Cosmo Pharmaceuticals, BioXell was a research and development biopharmaceutical company with globally recognized leadership in Vitamin D and its in-depth understanding of the molecular basis of inflammation. The company was initially listed on the Swiss stock exchange prior to its acquisition.

Company: bioxell

Fund: Alpinvest

Status: Realized

Team member:

Harrold van Barlingen

19.jpg
 

Technology:

Therapeutics

Therapeutics.png